Atomoxetine Hydrochloride
"Atomoxetine Hydrochloride" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A propylamine derivative and selective ADRENERGIC UPTAKE INHIBITOR that is used in the treatment of ATTENTION DEFICIT HYPERACTIVITY DISORDER.
Descriptor ID |
D000069445
|
MeSH Number(s) |
D02.092.831.085
|
Concept/Terms |
Atomoxetine Hydrochloride- Atomoxetine Hydrochloride
- Hydrochloride, Atomoxetine
- N-methyl-gamma-(2-methylphenoxy)benzenepropanamine hydrochloride
- Atomoxetine HCl
- HCl, Atomoxetine
|
Below are MeSH descriptors whose meaning is more general than "Atomoxetine Hydrochloride".
Below are MeSH descriptors whose meaning is more specific than "Atomoxetine Hydrochloride".
This graph shows the total number of publications written about "Atomoxetine Hydrochloride" by people in this website by year, and whether "Atomoxetine Hydrochloride" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2014 | 0 | 1 | 1 |
2017 | 0 | 1 | 1 |
2018 | 3 | 1 | 4 |
2019 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Atomoxetine Hydrochloride" by people in Profiles.
-
[Adult attention deficit hyperactivity disorder (ADHD) with comorbid addictive disorder. Therapeutic challenges using the example of a survey of clinical practice]. MMW Fortschr Med. 2019 Jul; 161(Suppl 5):7-12.
-
Light up ADHD: II. Neuropharmacological effects measured by near infrared spectroscopy: is there a biomarker? J Affect Disord. 2019 02 01; 244:100-106.
-
Drug pair shows promise for treating sleep apnea. Science. 2018 09 21; 361(6408):1174-1175.
-
Trends in attention-deficit hyperactivity disorder medication use: a retrospective observational study using population-based databases. Lancet Psychiatry. 2018 10; 5(10):824-835.
-
The Effect of Methylphenidate and Atomoxetine on Heart Rate and Systolic Blood Pressure in Young People and Adults with Attention-Deficit Hyperactivity Disorder (ADHD): Systematic Review, Meta-Analysis, and Meta-Regression. Int J Environ Res Public Health. 2018 08 20; 15(8).
-
Cardiovascular Effects of Stimulant and Non-Stimulant Medication for Children and Adolescents with ADHD: A Systematic Review and Meta-Analysis of Trials of Methylphenidate, Amphetamines and Atomoxetine. CNS Drugs. 2017 Mar; 31(3):199-215.
-
A nationwide study of attention-deficit/hyperactivity disorder drug use among adults in Iceland 2003-2012. Basic Clin Pharmacol Toxicol. 2014 Nov; 115(5):417-22.